FPN || Gastroenterology

Vitamin D appears protective in patients with metastatic colorectal cancer

Posted on: 17/01/2015 - 18:34

SAN FRANCISCO – Patients with metastatic colorectal cancer fared better if they had higher pretreatment levels of vitamin D, according to a prospective analysis from a phase III trial. On average,...

Field of Interest: Gastroentero...

Type: News Item

Vitamin D appears protective in patients with metastatic colorectal cancer

Posted on: 17/01/2015 - 18:34

Field of Interest: Oncology

Type: News Item

Aetna customers to receive discount on Gilead’s hepatitis C treatment

Posted on: 16/01/2015 - 21:06

Gilead Sciences Inc. and Aetna Inc. have announced a partnership wherein the drug company will offer Aetna’s approximately 20 million health plan me... More »

Field of Interest: Gastroentero...

Type: News Item

Analysis: Push for expanded hepatitis C screening appears premature

Posted on: 13/01/2015 - 23:30

The recent advent of new treatments for hepatitis C prompted organizations including the Centers for Disease Control and Prevention, the U.S. Preventi... More »

Field of Interest: Gastroentero...

Type: News Item

Microbiota organization influences colorectal cancers

Posted on: 12/01/2015 - 13:13

The way in which microbial communities are organized in the mucosa of the colon could be a critical factor in the development of some colorectal cancers, researchers said. The presence of bacterial...

Field of Interest: Gastroentero...

Type: News Item

Microbiota organization influences colorectal cancers

Posted on: 12/01/2015 - 13:13

Field of Interest: Oncology

Type: News Item

Gilead’s hepatitis C drugs to be sold exclusively at CVS

Posted on: 06/01/2015 - 18:09

Gilead Sciences Inc. scored an exclusive deal with CVS Health Corp., as its two hepatitis C medicines, Harvoni and Sovaldi, will be available only for CVS customers. Sovaldi costs $84,000 for a...

Field of Interest: Gastroentero...

Type: News Item

HCV continuum critical to providing better care in urban areas

Posted on: 22/12/2014 - 13:03

By mapping the testing and care of patients with the hepatitis C virus on a continuum, health care providers can get a better picture of the stages at which the disease is being managed effectively...

Field of Interest: Gastroentero...

Type: News Item

FDA approves four-drug combination for HCV

Posted on: 19/12/2014 - 21:51

The Food and Drug Administration has approved the four-drug combination package Viekira Pak for the treatment of hepatitis C virus genotype 1 infection with or without cirrhosis, the agency announced...

Field of Interest: Gastroentero...

Type: News Item

Diet, exercise reduced portal hypertension in obese cirrhotic patients

Posted on: 10/12/2014 - 19:56

BOSTON – A 16-week diet and exercise program reduced body weight and portal pressure in a prospective pilot study of 50 obese patients with cirrhosis and portal hypertension. Twenty-six patients...

Field of Interest: Gastroentero...

Type: News Item

« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters